Elevance Health, Inc. (ELV) stock analysis
Healthcare · Healthcare Plans
From the 10-K filed 2026-02-06
Business type: Franchise
How it makes money
Elevance Health earns revenue by collecting fixed risk-based premiums, administrative fees, and pharmacy service charges from approximately 45.2 million medical members.
The company generates revenue across four reportable segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. Within Health Benefits, it offers managed care risk-based plans to Individual, Employer Group, Medicaid, and Medicare markets, collecting premiums that are generally fixed for a 12-month period.
In addition to risk-based products, it provides managed care services to fee-based customers through administrative fees, covering claims processing and network access. Through CarelonRx and Carelon Services, the company captures additional pharmacy and health service fees both from its own health plans and from unaffiliated customers.
What protects it: the moat
Management asserts that competitive advantages stem from national scale, local market focus, and licensed operation as an independent Blue Cross and Blue Shield licensee.
The company relies on its status as an independent licensee of the Blue Cross and Blue Shield Association to operate under well-recognized brand names across designated states. It maintains that combining national scale with local market presence allows it to negotiate provider contracts and foster value-based payment models.
However, the filing presents these competitive positioning elements largely as management's strategies and beliefs rather than insurmountable economic moats, noting that profitability remains vulnerable to pricing errors and rising medical cost trends.
What growth costs
The filing does not disclose specific figures for capital expenditures, store builds, or R&D investments required to grow earnings.
While the company states that it expects to rationalize its portfolio and align investments to optimize core businesses and pursue high-growth opportunities, the provided text does not quantify the exact monetary amounts required for these reinvestments.
Operating expenses, cost of products sold, and benefit expenses are deducted in determining operating gain, but the specific capital allocation totals for maintaining or expanding infrastructure are omitted from the excerpted sections.
What could damage it
Inability to accurately predict and price for healthcare costs causes actual expenses to exceed fixed premiums, permanently impairing operating profitability.
Commercial and Medicaid premiums are typically fixed for a 12-month period based on historical data, while Medicare revenue relies on bids submitted months in advance to CMS. If medical cost inflation, unfavorable utilization patterns, or changes in member acuity outpace these fixed rates, the excess costs cannot be recovered within that contract year.
Because reserves and benefit cost projections involve extensive judgment, unexpected unfavorable claims experience directly increases incurred losses and reduces net earnings without the ability to retroactively adjust pricing.
About Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.